From: Cardiac magnetic resonance imaging in patients with Behçet's disease
Variables | With normal cardiac MRI )n = 5( (% = 16.67) | With abnormal cardiac MRI (n = 25( (% = 83.33) | P value |
---|---|---|---|
Demographic and clinical characteristics | |||
Age (years), M ± SD | 26.0 ± 2.65 | 33.56 ± 9.22 | .084 |
Sex | |||
Male, n (%) | 2 (40) | 19 (76) | .109 |
Female, n (%) | 3 (60) | 6 (24) | |
Behçet's disease duration (years), median (min–max) | 2 (2–3) | 3 (1–7) | .176 |
Height (cm), M ± SD | 171.6 ± 4.77 | 170.92 ± 5.71 | .723 |
Weight (kg), M ± SD | 74 ± 8.22 | 75.64 ± 9.54 | .723 |
BMI (kg/m2), M ± SD | 25.08 ± 1.86 | 25.96 ± 3.6 | .60 |
Heart rate (bpm), M ± SD | 88 ± 4.47 | 89.9 ± 8.23 | .641 |
SBP (mmHg), M ± SD | 124 ± 5.47 | 128.2 ± 6.59 | .19 |
DBP (mmHg), M ± SD | 70 ± 7.07 | 80 ± 9.13 | .806 |
Behcet disease activity index score, M ± SD | |||
≤ 4, n (%) | 1(20) | 14(56) | .33 |
> 4, n (%) | 4(80) | 11(44) | |
Cumulative manifestations of Behcet disease | |||
Orogenital Ulcers | 5(100) | 25(100) | 1 |
Uveitis | 4(80.0) | 19(76.0) | 1 |
Cutaneous manifestations | 1(20.0) | 10(40.0) | .63 |
Musculoskeletal manifestations | 2 (40) | 8 (32) | 1 |
Gastrointestinal tract manifestations | 1 (20) | 1(4) | 1 |
Deep venous thrombosis | 1(20) | 3 (12) | .53 |
Laboratory characteristics | |||
Complete blood count | |||
Hb (g/dL), M ± SD | 11.90 ± 0.74 | 11.82 ± 1.07 | .88 |
WBCs (103 /mm3), M ± SD | 4.26 ± 0.78 | 4.71 ± 0.71 | .21 |
PLT (103 /mm3), M ± SD | 225.0 ± 32.02 | 222.36 ± 57.48 | .92 |
Serum creatinine (mg/dL), M ± SD | 0.86 ± 0.09 | 0.916 ± 0.11 | .312 |
Erythrocyte sedimentation rate (mm/hr), M ± SD | 33.0 ± 12.04 | 33.0 ± 12.04 | .58 |
Positive C-reactive protein, n (%) | 2(40) | 12(48) | 1 |
Medications used for treatment, n (%) | |||
Colchicine | 5 (100) | 25 (100) | 1 |
Steroids | 5 (100) | 25 (100) | 1 |
Azathioprine | 4 (80) | 10 (40) | .157 |
Cyclosporine | 1 (20) | 11 (44) | .62 |
Anticoagulants | 1 (20) | 4 (16) | 1 |
Biological agents | 1 (20) | 9 (36) | .64 |